Reliable release testing for nanoparticles with the NanoDis System, an innovative sample and separate technique

Area of Science:

• Pharmaceutical Sciences
• Nanotechnology
• Drug Delivery

Background:

• Drug release is a critical quality attribute for nanoparticle formulations.
• Standardized methods for extended-release nanoformulation testing are lacking.
• Dialysis techniques have limitations, including masking burst release and slow permeation.

Purpose of the Study:

• To characterize the release profile of poly(lactic co-glycolic) acid (PLGA) nanocapsules containing all-trans retinoic acid.
• To compare the NanoDis System with traditional dialysis techniques for release testing.
• To evaluate the NanoDis System's ability to accurately measure burst release and discriminate between formulations.

Main Methods:

• Utilized the innovative NanoDis System, a sample and separate setup.
• Characterized the release of all-trans retinoic acid from PLGA nanocapsules.
• Compared NanoDis System results with those obtained from a dialysis technique.

Main Results:

• The NanoDis System demonstrated clear superiority over the dialysis method.
• The NanoDis System accurately characterized burst release from nanocapsules.
• The NanoDis System effectively discriminated between different all-trans retinoic acid nanoparticle formulations.

Conclusions:

• The NanoDis System is a superior method for characterizing drug release from extended-release nanoformulations.
• This system overcomes the drawbacks associated with dialysis techniques.
• The NanoDis System provides accurate and discriminative release profiles, crucial for quality control.